On the other hand, sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as empagliflozin, are reported to cause rare hypersensitivity reactions present as angioedema, which are more known to be histamine-mediated. The gene discussed is SLC5A2; the disease is angioedema.